Sanjay Bhagani

Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study

G. Dore, M. van der Valk, S. Barbieri, 2023, Journal of the International AIDS Society.

Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection

G. Cooke, G. Dore, C. Orkin, 2018, Journal of viral hepatitis.

The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men.

C. Sabin, A. Phillips, S. Bhagani, 1997, The Journal of infectious diseases.

Baseline prevalence and predictors of liver fibrosis among HIV‐positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

M. Doroana, SH Mehta, E. Vlahakis, 2015, HIV medicine.